Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
3,418,857
-
Share change
-
+253,718
-
Total reported value
-
$568,580,158
-
Price per share
-
$166.21
-
Number of holders
-
253
-
Value change
-
+$41,645,148
-
Number of buys
-
100
-
Number of sells
-
106
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2024
As of 31 Dec 2024,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
253 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,418,857 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, LPL Financial LLC, RAYMOND JAMES FINANCIAL INC, Berger Financial Group, Inc, Royal Bank of Canada, ENVESTNET ASSET MANAGEMENT INC, and Csenge Advisory Group.
This page lists
253
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.